The markets opened higher with the Dow gaining 42 points to 10,969 as pending home sales surged 8.2% in February. Nasdaq climbed 16 points to 2419.
On the upside
The Food and Drug Administration granted Keryx Biopharmaceuticals' (Nasdaq: KERX) refractory advanced colorectal cancer treatment KRX-0401 Fast Track status.
J. P. Morgan upgraded Melco Crown Entertainment (Nasdaq: MPEL).